Patent · US Active

RNA interference in skin indications

US9303259B2 · kind B2 · utility

44Cited by

122References

12Claims

0Family size

Assignee

RXi Pharmaceuticals Corporation · US

Inventors

Anastasia Khvorova · Boulder, US
William Salomon · Worcester, US
Joanne Kamens · Newton, US
Dmitry Samarsky · Berlin, DE
Tod M. Woolf · Sudbury, US
Pamela Pavco · Longmont, US
James Cardia · Franklin, US

Key dates

Filing date	Dec 12, 2013
Grant date	Apr 5, 2016
Priority date	—
Expiry date	Dec 12, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/53
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to RNAi constructs with improved tissue and cellular uptake characteristics and methods of use of these compounds in dermal applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.